Clinical Study

Hiv Prevention Study

Posted Date: Jun 17, 2021

  • Investigator: Moises Huaman
  • Specialties:
  • Type of Study: Drug

A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People = 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection




Hiv, Prevention

For More Information:

Sharon Kohrs, Rn

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.